Conclusions : Pooled analyses show that barley β-glucan has a lowering effect on LDL-C and non-HDL-C. Inclusion of barley-containing foods may be a strategy for achieving targets in CVD risk reduction
Background / Objectives : There has been recent interest in barley as a therapeutic food owing to its high content of beta-glucan ( β-glucan ) , a viscous soluble fiber recognized for its cholesterol-lowering properties .
The objective of this study was to conduct a systematic review and meta- analysis of r and omized controlled trials ( RCTs ) investigating the cholesterol-lowering potential of barley β-glucan on low-density lipoprotein cholesterol ( LDL-C ) , non-high-density lipoprotein cholesterol ( non-HDL-C ) and apolipoprotein B ( apoB ) for cardiovascular disease ( CVD ) risk reduction .
Barley and wheat foods: influence on plasma cholesterol concentrations in hypercholesterolemic men.
Twenty-one mildly hypercholesterolemic men aged 30 - 59 y were provided with comparable barley and wheat foods for each of 4 wk in a crossover- design ed experiment . The purpose of the study was to examine the influence of two sources of dietary fiber ( nonstarch polysaccharides , NSP ) on blood lipids and glucose concentrations .  Barley contains beta-glucan as a source of soluble dietary fiber ( DF ) whereas wheat contains the largely insoluble cellulose and hemicellulose fiber . Total dietary fiber increased from a previous intake of 21 - 38 g/d during the period of study for the two groups . Consumption of barley relative to wheat foods was associated with a significant fall in both plasma total cholesterol ( 6 % , P less than 0.05 ) and in low-density-lipoprotein cholesterol ( 7 % , P less than 0.02 ) whereas triglyceride and glucose concentrations did not change significantly . It is concluded that barley dietary fiber is more effective than wheat dietary fiber at lowering blood cholesterol in hypercholesterolemic men
Conclusions : Pooled analyses show that barley β-glucan has a lowering effect on LDL-C and non-HDL-C. Inclusion of barley-containing foods may be a strategy for achieving targets in CVD risk reduction
Background / Objectives : There has been recent interest in barley as a therapeutic food owing to its high content of beta-glucan ( β-glucan ) , a viscous soluble fiber recognized for its cholesterol-lowering properties .
The objective of this study was to conduct a systematic review and meta- analysis of r and omized controlled trials ( RCTs ) investigating the cholesterol-lowering potential of barley β-glucan on low-density lipoprotein cholesterol ( LDL-C ) , non-high-density lipoprotein cholesterol ( non-HDL-C ) and apolipoprotein B ( apoB ) for cardiovascular disease ( CVD ) risk reduction .